Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Frontiers in Oncology|November 17, 2022
Association of inflammatory markers with survival in patients with advanced gastric cancer treated with immune checkpoint inhibitors combined with chemotherapy as first line treatmentMingyu Wan, Yongfeng Ding, Chenyu Mao, et al.
Cancer Chemotherapy and Pharmacology|May 28, 2015
A phase II study of biweekly S-1 and paclitaxel (SPA) as first-line chemotherapy in patients with metastatic or advanced gastric cancerHaiping Jiang, Jiong Qian, Peng Zhao, et al.
Journal of Thoracic Disease|March 8, 2014
A study of weekly docetaxel and carboplatin as first-line chemotherapy for advanced non-small cell lung cancerHaiping Jiang, Xiaochen Zhang, Jing Chen, et al.
Oncology Letters|July 3, 2015
Neurokinin-2 receptor polymorphism predicts lymph node metastasis in colorectal cancer patientsWeijia Fang, Caiyun Fu, Xiaogang Chen, et al.
Journal of Hematology & Oncology|December 31, 2024
Dual inhibition of LAG-3 and PD-1 with IBI110 and sintilimab in advanced solid tumors: the first-in-human phase Ia/Ib studyChenyu Mao, Anwen Xiong, Jiong Qian, et al.
Medical Oncology (Northwood, London, England)|March 15, 2011
Phase II trial of gefitinib in pretreated Chinese women with advanced non-small-cell lung cancerJing Deng, Wei Jia Fang, Xiao Chen Zhang, et al.
BMC Cancer|August 16, 2020
Safety and efficacy of sintilimab combined with oxaliplatin/capecitabine as first-line treatment in patients with locally advanced or metastatic gastric/gastroesophageal junction adenocarcinoma in a phase Ib clinical trialHaiping Jiang, Yulong Zheng, Jiong Qian, et al.
Cancer Immunology, Immunotherapy : CII|October 18, 2020
Efficacy and safety of sintilimab in combination with chemotherapy in previously untreated advanced or metastatic nonsquamous or squamous NSCLC: two cohorts of an open-label, phase 1b studyHaiping Jiang, Yulong Zheng, Jiong Qian, et al.
American Journal of Cancer Research|October 18, 2021
Assessment of TMB, PD-L1, and lymphocyte to monocyte ratio as predictive potential in a phase Ib study of sintilimab in patients with advanced solid tumorsHaiping Jiang, Ning Li, Huan Wang, et al.
BMC Infectious Diseases|October 1, 2014
Clostridium difficile carriage in hospitalized cancer patients: a prospective investigation in eastern ChinaWei-Jia Fang, Da-Zhi Jing, Yun Luo, et al.
Pageof 2